跳至主要内容
临床试验/NCT02728856
NCT02728856已完成不适用

Evaluation of the Irritation Potential of Products in Human Eyes

Bayer1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2016年2月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Bayer
入组人数
48
试验地点
1
主要终点
Intensity of Bulbar Conjunctiva Irritation assessed by 4 grading scale

研究概览

简要总结

To evaluate the human eye irritation potential of two test sunscreen formulation

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Must be healthy males or females between the ages of 18 to 60 years inclusive with no medical conditions of the eyes.
  • Do not wear contact lenses or, if he/she does wear contact lenses, is willing to refrain from wearing these during the test period.
  • Willing to report any medications taken during the study.
  • Willing to have the test materials instilled into the eyes and follow all protocol requirements.
  • Have been informed and have given written consent to participate in the study.

排除标准

  • Has ocular disease or peri-orbital dermatitis or trauma, infections or chronic eye conditions that may affect the study outcome.
  • Has systemic illness which affects the eyes, including diabetes, thyroid disease, sarcoidosis, hypertension, atherosclerosis, lupus, multiple sclerosis, sickle cell disease, acquired immune deficiency syndrome (AIDs), severer rheumatoid arthritis. results as determined by the investigator.
  • Must not have a history of pre-existing sensitivity or other types of allergy to any eye products.
  • Must not have received and used an Investigational New Drug within the thirty days immediately preceding the study.

结局指标

主要结局

Intensity of Bulbar Conjunctiva Irritation assessed by 4 grading scale

时间窗: Up to 1 day

Intensity of Lacrimation assessed by 5 grading scale

时间窗: Up to 1 day

Subjective assessment of discomfort in the eyes assessed by 5 point scale

时间窗: Up to 1 day

Intensity of Palpebral Conjunctiva Irritation assessed by 4 grading scale

时间窗: Up to 1 day

次要结局

未报告次要终点

研究者

发起方
Bayer
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验